Rejected from PLOS Biology? Where to Submit Next

This guide was checked on July 17, 2026 against current PLOS Biology submission, journal-information, what-we-publish, and submit-now pages, plus PLOS transfer-policy language from the PLOS ONE editorial-process page.

Source-supported facts used here:

• PLOS Biology describes its scope as all areas of biological science and every scale from molecules to ecosystems, including interfaces with other disciplines.
• PLOS Biology says it evaluates research based on the important questions answered and potential impact on an international scientific community, educators, policy makers, patient advocacy groups, and society more broadly.
• PLOS Biology's criteria for publication emphasize significant advances, broad impact, and high scientific rigor in methodology, reporting, and conclusions.
• The journal publishes multiple research-based formats, including Research Articles, Preregistered Research Articles, Methods & Resources Articles, Meta-Research Articles, Short Reports, Discovery Reports, and Update Articles.
• PLOS Biology says initial research-article submission is format-free, with a mini form that takes about 10 minutes, and that no journal-specific formatting is required until close to acceptance.
• PLOS Biology says manuscripts can be any length, with no restriction on word count, number of figures, or amount of supporting information.
• PLOS Biology's submit-now page says it is open to considering manuscripts on the basis of prior reviews from journals at other publishers, if authors include prior-review details and a point-by-point response.
• PLOS transfer language says authors can request transfer of submissions, with reviewer reports if relevant, from one PLOS journal to another for consideration, and that manuscripts are not transferred without author consent.
• PLOS Biology's journal-information page links to current staff-editor and editorial-board pages, and its submit-now page links authors to the Editorial Manager submission portal.
• PLOS's current publication-fees page lists a PLOS Biology Research Article APC of $5,500, with lower listed fees for some article types such as Update Articles and Discovery Reports. Fees are volatile and should be verified before submission.
• PLOS Biology's journal-information page cites the PLOS Biology editorial DOI 10.1371/journal.pbio.2005203 for its complementary-research policy context.

Facts intentionally avoided or caveated:

• No current acceptance rate, impact factor, appeal success rate, or exact rejection probability is stated as a live fact on this page. The APC detail is included only because PLOS's current fees page supports it, and it is caveated as volatile.
• Existing Manusights PLOS Biology pages were used for sibling contradiction checks and internal routing, not as source of truth for volatile facts.

PLOS Biology rejection signals are useful only if you translate them into a next-journal route.

The central question is whether PLOS Biology rejected the flagship-biology claim or the evidence package. A flagship-claim rejection can route quickly. An evidence-package rejection usually follows the paper.

Do not treat this as a simple prestige ladder. A PLOS Biology rejection can mean the work is too narrow for a flagship venue, but it can also mean the paper needs a different article type, a cleaner methods package, a stronger general-biology framing, or a direct response to prior peer-review concerns.

Rebuilding for PLOS Biology is plausible only when the paper still has a broad biological reason to exist.

Good reasons to rebuild:

• The study answers a biological question that matters outside one organism, tissue, dataset, assay, population, or model.
• The rejection exposed a fixable framing gap rather than a fatal design problem.
• The paper can show a significant advance with current data, controls, analysis, reporting, and limitations.
• The article type can be clarified without changing the scientific contract.
• Prior reviews can be answered in a way that makes the next editor's job easier.

Bad reasons to rebuild:

• You mainly want to stay near the same perceived journal tier.
• The strongest contribution is a useful specialist result, not a flagship biology advance.
• The methods, controls, sample size, code, data access, or validation package cannot support the central claim.
• The manuscript would be stronger as a genetics, computational biology, methods, ecology, microbiology, neuroscience, or sound-science paper.

If you rebuild, make the new owner visible early. The title, abstract, first figure, methods transparency paragraph, data statement, limitations, and cover letter should all explain the same biological advance.

PLOS has two separate routing ideas authors often confuse.

First, PLOS transfer language says authors can request transfer from one PLOS journal to another, with reviewer reports where relevant, and that transfer requires author consent. This can reduce resubmission friction if the next PLOS journal is genuinely a better fit.

Second, PLOS Biology's own submit-now page says it is open to considering manuscripts based on reviews from other publishers, if authors disclose the prior journal and manuscript ID and upload prior reports with a point-by-point response as a Prior Peer Review file type.

Use these routes only when they help the editor understand a repaired manuscript. Do not use transfer mechanics to move the same unresolved problem faster.

In our pre-submission review work on PLOS Biology submissions, the strongest predictor is whether the manuscript has a stable general-biology owner from title to conclusion. The paper cannot merely be good within a niche. It has to make a biological claim that an editor can imagine mattering to readers outside the immediate subfield.

Manusights internal analysis treats this as a specific rejection pattern: the abstract, first figure, methods, data statement, limitations, prior-review response, and cover letter must all answer the same general-biology question. We see the same failure when authors revise only the cover letter after rejection while leaving the manuscript's evidence shape unchanged.

Four specific failure patterns decide the next route.

PLOS Biology local-result framing. The manuscript has strong data, but the title and abstract read like a result for one model system, disease context, organism, dataset, or assay. The repair is to name the biological question the system answers. If that broader question is not really supported, choose a specialist venue.

PLOS Biology rigor-gap carryover. The rejection letter mentions controls, validation, replication, code, data access, reporting, or analysis transparency. That problem follows the manuscript. Sending the same file to BMC Biology, Communications Biology, PLOS Genetics, or PLOS Computational Biology without repair usually just delays the next rejection.

PLOS Biology article-type confusion. Some papers are not wrong scientifically; they are the wrong artifact. A technical resource, negative update, exploratory discovery, registered design, meta-research study, or brief report should not be forced into a standard full research-article story if the evidence shape says otherwise.

PLOS Biology wrong-neighbor ownership. If the manuscript is mainly genetics, PLOS Genetics may be cleaner. If the contribution is computational, PLOS Computational Biology may be cleaner. If the paper is rigorous but not broad-importance, PLOS ONE may be cleaner. If the work is broad but not PLOS-specific, eLife, BMC Biology, or Communications Biology may be better.

The highest-risk rejected PLOS Biology packages fail before the next journal evaluates the final figure. The abstract promises a broad biological advance, the first figure shows a narrower phenomenon, the methods support only one setting, and the cover letter never tells the next editor why a general biology reader should care. Editors explicitly screen for fit before external review, so this mismatch can repeat quickly at the next selective biology journal.

Before resubmission, we check whether the title, abstract, first figure, methods, prior-review response, data statement, limitations, and cover letter all make the same promise. If they do not, the next editor will see a manuscript still carrying its PLOS Biology rejection.